Colowatch

ColoWatch is the trusted authority in CT Colonography (CTC), providing a comprehensive, turnkey solution for healthcare facilities to expand access to this life-saving colorectal cancer screening. Our mission is to establish CTC as the new standard of care, making it more accessible, accurate, and patient-friendly. Led by a team of healthcare technology experts and world-renowned radiologists, including CEO Bikram Bakshi (leader of the Healthcare.gov turnaround) and President Dr. Mark Klein (over CTC studies performed), ColoWatch is founded on a bedrock of clinical rigor and standardized methodology. Our "Smarter, Safer, Better" approach to colorectal cancer screening offers: • Smarter:>95% accuracy on positive results for significant polyps/cancer and the ability to detect other potential health issues (extracolonic findings). • Safer: A non-invasive procedure with no sedation required, avoiding the risks associated with traditional colonoscopy. • Better: A 15-minute exam that allows for multiple, detailed 3D reviews of the colon, increasing diagnostic confidence. We partner with imaging centers and healthcare systems to provide a complete ecosystem for CTC, including our secure, cloud-based 3D imaging software, a network of expert radiologists, and standardized clinical protocols. As an approved screening option by the USPSTF and the American Cancer Society, with Medicare reimbursement effective January 1, 2025, the time to embrace CTC is now. Join us in our mission to close the screening gap and save lives.